Fingerprint
Dive into the research topics of 'Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically